Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 57 entries
View as:

Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose

Phase: N/A Priority: Normal
NCT ID: NCT02017327 Org: User:
Start: 12/31/13 End: 07/31/16 Due: 07/31/17

Efficacy and Safety of T1225 1.5% Versus Tobramycin 0.3 % in the Treatment of Purulent Bacterial Conjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT00357773 Org: User:
Start: 05/31/04 End: 06/30/05 Due: 06/30/06

Comparison of the Efficacy and Safety of T2750 and Vismed® in the Treatment of Moderate to Severe Dry Eye Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01568593 Org: User:
Start: 03/31/12 End: 03/31/13 Due: 03/31/14

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Phase: N/A Priority: Normal
NCT ID: NCT05158296 Org: User:
Start: 12/08/21 End: 10/12/22 Due: 10/12/23

Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01552174 Org: User:
Start: 03/31/12 End: 04/30/14 Due: 04/30/15

Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

Phase: N/A Priority: Normal
NCT ID: NCT01091311 Org: User:
Start: 05/31/10 End: 12/31/10 Due: 12/31/11

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

Phase: N/A Priority: Normal
NCT ID: NCT01156012 Org: User:
Start: 09/30/09 End: 12/31/10 Due: 12/31/11

Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01494753 Org: User:
Start: 06/30/08 End: 12/31/08 Due: 12/31/09

Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04803240 Org: User:
Start: 04/01/19 End: 03/30/20 Due: 03/30/21

Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)

Phase: N/A Priority: Normal
NCT ID: NCT06891443 Org: User:
Start: 08/31/25 End: 10/31/28 Due: 10/31/29

Performance and Safety Assessment of T2769 in Contact Lens Wearers With Dry Eye Symptoms.

Phase: N/A Priority: Normal
NCT ID: NCT05931861 Org: User:
Start: 08/15/23 End: 12/04/23 Due: 12/04/24

Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients.

Phase: N/A Priority: Normal
NCT ID: NCT05389267 Org: User:
Start: 07/05/22 End: 12/31/24 Due: 12/31/25

Efficacy of T2259 in DED

Phase: N/A Priority: Normal
NCT ID: NCT03874429 Org: User:
Start: 04/24/19 End: 03/25/21 Due: 03/25/22

Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02101359 Org: User:
Start: 06/30/11 End: 05/31/13 Due: 05/31/14

Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

Phase: N/A Priority: Normal
NCT ID: NCT06375499 Org: User:
Start: 09/17/24 End: 01/06/25 Due: 01/06/26

Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

Phase: N/A Priority: Normal
NCT ID: NCT01155999 Org: User:
Start: 12/31/08 End: 02/28/11 Due: 02/28/12

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

Phase: N/A Priority: Normal
NCT ID: NCT05176717 Org: User:
Start: 12/15/21 End: 08/02/22 Due: 08/02/23

Efficacy of T1675 Versus Placebo in Patients With Bilateral Treated Moderate Dry Eye Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00357201 Org: User:
Start: 11/30/04 End: 05/31/05 Due: 05/31/06

Systemic Pharmacokinetic Study of T4032 (Unpreserved Bimatoprost 0.01%) Eye Gel Versus Lumigan® 0.01% Eye Drops in 40 Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05729594 Org: User:
Start: 02/27/23 End: 04/05/23 Due: 04/05/24

Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients with Open-angle Glaucoma or Ocular Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT06394973 Org: User:
Start: 08/05/24 End: 05/31/25 Due: 05/31/26

Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00356772 Org: User:
Start: 02/28/03 End: 03/31/03 Due: 03/31/04

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT01794312 Org: User:
Start: 02/28/13 End: 12/19/17 Due: 12/19/18

Efficacy and Safety of GV 550 in Acute Adenovirus Keratoconjunctivitis

Phase: N/A Priority: Normal
NCT ID: NCT01156025 Org: User:
Start: 03/31/09 End: 06/30/10 Due: 06/30/11

Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.

Phase: N/A Priority: Normal
NCT ID: NCT04898387 Org: User:
Start: 03/26/21 End: 05/30/23 Due: 05/30/24

Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01203540 Org: User:
Start: 10/31/10 End: 01/31/11 Due: 01/31/12